WATERS HONORS SINGAPORE'S BIOPROCESSING TECHNOLOGY INSTITUTE (BTI) FOR GLYCOSCIENCE RESEARCH

Waters Instrumentation and Expertise to Assist with BTI’s Glycoanalytics and Glycobiotechnology Research MILFORD, Mass, Feb 28 (Bernama-BUSINESS WIRE) -- At a ceremony and symposium today, Waters Corporation (NYSE:WAT) welcomed into its Centers of Innovation Program the Bioprocessing Technology Institute (BTI), a research institute under Singapore’s Agency for Science, Technology and Research (A*STAR). BTI is the first research institute1 focused on glycobiology to participate in the Waters Centers of Innovation Program. Glycans, or sugars, are one of the four fundamental classes of macromolecules that comprise living systems. BTI’s glycan research is aimed at finding novel cancer markers and elucidating glycosylation pathways that could pave the way for new therapeutic strategies.

http://mrem.bernama.com/mrembm/viewsm.php?idm=9788